ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 105,78
0,81%
Dow Jones
38 497,21
0,67%
DAX
18 137,65
1,60%
Brent Oil
87,215
0,93%
Bitcoin
66 704,49
-0,23%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. NovaBay Pharmaceuticals Inc New (NBY)

  7. NovaBay Pharmaceuticals Inc New (NBY) Actualités

NBY NovaBay Pharmaceuticals Inc New

0,0747
0,0022 (3,03%)
Dernière mise à jour : 18:46:36
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
NovaBay Pharmaceuticals Inc New NBY AMEX Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0022 3,03% 0,0747 18:46:36
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,0703 0,068 0,0759 0,0725
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
22/4/202412:57BWNovaBay Pharmaceuticals Announces New and Enhanced..
20/4/202400:00BWNovaBay Pharmaceuticals Receives a NYSE American Notice..
17/4/202412:59BWNovaBay Pharmaceuticals Reports Preliminary Eyecare and..
26/3/202421:05BWNovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full..
25/3/202423:38BWNovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full..
14/3/202413:00BWNovaBay Pharmaceuticals Announces Agreement to Sell its..
14/2/202420:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202417:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/1/202415:00BWNovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in..
10/1/202414:00EDGAR2Form 8-K - Current report
09/1/202415:15BWNovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to..
04/1/202417:50EDGAR2Form D - Notice of Exempt Offering of Securities
21/12/202313:58EDGAR2Form 8-K - Current report
11/12/202322:32EDGAR2Form 8-K - Current report
06/12/202312:50BWNovaBay Pharmaceuticals Partners with Woo University to..
09/11/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:05BWNovaBay Pharmaceuticals Reports Third Quarter 2023 Financial..
02/11/202311:50BWNovaBay Pharmaceuticals to Hold Third Quarter 2023..
11/10/202314:00BWNovaBay Pharmaceuticals Expands Physician Dispensed Sales..
02/10/202312:50BWNovaBay Pharmaceuticals to Present at the Dawson James Small..
21/9/202315:35GLOBEDawson James Securities Announces October Date for 8th..
14/9/202314:00BWNovaBay Pharmaceuticals Announces Commercial Launch of..
11/9/202314:00BWNovaBay Pharmaceuticals Announces Agreement with BioStem..
10/8/202322:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:05BWNovaBay Pharmaceuticals Reports Second Quarter 2023..
08/8/202322:05BWNovaBay Pharmaceuticals to Hold Second Quarter 2023..
14/7/202314:30BWNovaBay Pharmaceuticals Reports Record Avenova Sales Day
10/7/202312:50BWNovaBay Pharmaceuticals Announces Exclusive Amazon Prime Day..
07/7/202323:00EDGAR2Form 8-K - Current report
06/7/202323:00EDGAR2Form 8-K - Current report
28/6/202312:50BWNovaBay Pharmaceuticals Supports National Dry Eye Awareness..
20/6/202312:50BWNovaBay Pharmaceuticals to Showcase its Full Line of Avenova..
12/6/202312:50BWNovaBay Pharmaceuticals Announces DERMAdoctor’s KP Duty..
11/5/202322:05BWNovaBay Pharmaceuticals Reports First Quarter 2023 Financial..
05/5/202312:50BWPhaseOne Health Collaborates with Nonprofit Humanitarian..
04/5/202312:50BWNovaBay Pharmaceuticals to Hold First Quarter 2023..
01/5/202312:50BWNovaBay Pharmaceuticals Fulfills $1 Million Order for..
27/4/202322:47BWNovaBay Pharmaceuticals Announces $3.0 Million Convertible..

Dernières Valeurs Consultées

AMEX
NBY
NovaBay Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés